Royal Brompton and Harefield hospitals shared a post on LinkedIn:
“Great news for the future of cardio‑oncology care.
The new COMPASS consortium, a €50.5 million EU‑funded public‑private partnership under the Innovative Health Initiative (IHI), has officially launched, bringing together more than 60 partners across 25 countries to advance the early detection and management of cardiotoxicity in cancer patients.
As one of the leading academic partners, the Cardio‑Oncology Centre of Excellence at Royal Brompton and Harefield hospitals will contribute world‑class clinical and scientific expertise to this landmark programme.
Combining EU HORIZON IHI funding and matched industry investment, COMPASS aims to build integrated, AI‑enabled clinical pathways to improve cardiovascular outcomes for people living with and beyond cancer.
Dr Alex Lyon, Director of Royal Brompton’s Cardio‑Oncology Centre of Excellence, said:
‘This award will transform the health and improve outcomes for cancer patients with heart disease, so frequently caused by their life‑saving cancer treatments. We are delighted our centre is to be one of the leading academic partners in this new research consortium.’
Dr Sohaib Nazir, Consultant Cardiologist at Royal Brompton Hospital and Clinical Senior Lecturer at King’s College London, added:
‘We are looking forward to working with all our partners. Through a major partnership with academic lead King’s College London, our centre at the Royal Brompton Hospital and industry leads GE Healthcare, COMPASS has the potential to make really impactful changes for our patients.’ “
Siva Tharshini Ramalingam, Cardio-oncology Speciality Doctor at Royal Brompton and Harefield Hospitals, shared a post on LinkedIn:
“Huge congratulations to Dr Alex Lyon and Dr Sohaib Nazir on the launch of the COMPASS consortium – a €50.5 million EU-funded public-private partnership under the Innovative Health Initiative, bringing together over 60 partners across 25 countries to advance the early detection and management of cardiotoxicity in cancer patients.
Through the Cardio-Oncology Centre of Excellence at Royal Brompton and Harefield Hospitals, in partnership with King’s College London and industry leads including GE Healthcare, COMPASS will build integrated, AI-enabled clinical pathways to improve cardiovascular outcomes for people living with and beyond cancer. This is a landmark moment for our field.”
Other articles about cardio-oncology on OncoDaily.